Lynx1 Prevents Long-Term Potentiation Blockade and Reduction of Neuromodulator Expression Caused by Aß1-42 and JNK Activation.

Bychkov, M L; Vasilyeva, N A; Shulepko, M A; Balaban, P M; Kirpichnikov, M P; Lyukmanova, E N

Bychkov, M L; Vasilyeva, N A; Shulepko, M A; Balaban, P M; Kirpichnikov, M P; Lyukmanova, E N.

Affiliation

Bychkov ML; Lomonosov Moscow State University, Leninskie Gori 1, Moscow, 119234, Russia.
Vasilyeva NA; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklucho- Maklaya Str., 16/10, Moscow, 117997, Russia.
Shulepko MA; Lomonosov Moscow State University, Leninskie Gori 1, Moscow, 119234, Russia.
Balaban PM; Lomonosov Moscow State University, Leninskie Gori 1, Moscow, 119234, Russia.
Kirpichnikov MP; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklucho- Maklaya Str., 16/10, Moscow, 117997, Russia.
Lyukmanova EN; Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences, Butlerova Str., 5A, Moscow, 117485, Russia.

Acta Naturae ; 10(3): 57-61, 2018.

Article de En | MEDLINE | ID: mdl-30397527

Mots clés

Alzheimer disease; Ly6/uPAR; cognitive impairment; nicotinic acetylcholine receptor; ß-amyloid peptide

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Acta Naturae Année: 2018 Type de document: Article Pays d'affiliation: Russie Pays de publication: Russie

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google